SCHEMBL7862898

SCHEMBL7862898

NCC(=O)NC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)cc2)cn1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
GFER P55789 1/20 0.46
TSHR P16473 3/20 0.45
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KMT2A Q03164 1/20 0.44
CYP3A4 P08684 1/20 0.42
HTR1A P08908 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
NFKB1 P19838 1/20 0.42
CNR1 P21554 1/20 0.42
CYP2C19 P33261 1/20 0.42
ADRA1A P35348 1/20 0.42
BLM P54132 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867896 0.85 LMNA (0.49) LMNAALDH1A1GAAGFERTSHR
SCHEMBL7871597 0.85 LMNA (0.44) LMNAALDH1A1TSHRSMN1; SMN2KMT2A
SCHEMBL7867694 0.84 EPHX2 (0.43) LMNAALDH1A1TSHRSMN1; SMN2KMT2A
SCHEMBL7862846 0.84 LMNA (0.47) LMNAALDH1A1TSHRHTTSMN1; SMN2
SCHEMBL9018193 0.83 LMNA (0.53) LMNAALDH1A1GAAGFERTSHR
SCHEMBL7862735 0.83 P4HTM (0.56) LMNAKMT2A
SCHEMBL7862795 0.82 EGFR (0.44)
SCHEMBL7871727 0.82 CA2 (0.44) ALDH1A1SMN1; SMN2KMT2A
SCHEMBL9018152 0.82 LMNA (0.49) LMNATSHRHTTSMN1; SMN2KMT2A
SCHEMBL7867700 0.82 LMNA (0.45) LMNAALDH1A1TSHRHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed